EUVIMEDEUVIMED entdecken
Open Access

Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways

Limin Kang, Xiaolong Ma, Fakun Yu, Lei Xu, Li Lang

Journal of Microbiology and Biotechnology · 2024

DOI: 10.4014/jmb.2406.06048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Limin Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Puer People's Hospital, Puer 665000, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Flavonols, Signal Transduction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Puer City Science and Technology Program, Kunming University of Science and Technology Joint Medical Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseFlavonolsSignal TransductionMice, Inbred C57BLToll-Like Receptor 4LiverDiet, High-FatAnimalsMaleMiceTumor Necrosis Factor-alphaDisease Models, AnimalInflammationInterleukin-1betaNF-kappa BLipopolysaccharidesRNA, Ribosomal, 16STranscription Factor RelA

Stichwörter der Autor:innen

Dihydromyricetininflammatory responseintestinal floraliver protectionnon-alcoholic fatty liver diseasetoll-like receptor 4/nuclear factor κB

Substanzen

dihydromyricetinFlavonolsToll-Like Receptor 4Tlr4 protein, mouseTumor Necrosis Factor-alphaInterleukin-1betaNF-kappa BLipopolysaccharidesRNA, Ribosomal, 16STranscription Factor RelA

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Puer People's Hospital, Puer 665000, P.R. China.
  • Department of Reproductive Genetics Center, Puer People's Hospital, Puer 665000, P.R. China.
  • Department of Outpatient, Puer People's Hospital, Puer 665000, P.R. China.

Förderung

  • Puer City Science and Technology Program
  • Kunming University of Science and Technology Joint Medical Special Project

Zitieren

APA

Kang, L., Ma, X., Yu, F., Xu, L., & Lang, L. (2024). Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2406.06048

Vancouver

Kang L, Ma X, Yu F, Xu L, Lang L. Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2406.06048

BibTeX
@article{Kang2024,
  author = {Kang, Limin and Ma, Xiaolong and Yu, Fakun and Xu, Lei and Lang, Li},
  title = {Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2024},
  doi = {10.4014/jmb.2406.06048}
}
Kostenlos starten →